What is occipital neuralgia?
Occipital neuralgia refers to sharp, shooting pain arising at back of
the head or upper neck, and spreading either to the top of the skull,
or to the temple region. This is frequently associated with a dull
or throbbing pain behind the eye. It may occur on both sides. This
pain is often reproduced by applying mild pressure or tapping over
the greater or lesser occipital nerves at the back of the skull. Some
patients may have pins and needles or numbness over the scalp.
What are the causes of occipital neuralgia?
Occipital neuralgia may follow:
- trauma to the head or neck
- surgery to the back of the head or neck
- spinal instability (for example atlantoaxial subluxation in rheumatoid
arthritis)
- neuromas (‘lump’ formation in certain nerves)
- C2 nerve root entrapment by thickened ligaments in the upper neck
How is occipital neuralgia treated?
Initially, occipital neuralgia is treated with pain medications, local
anaesthetic injections, and physiotherapy. Steroids are sometimes used
in the short-term. Avoidance of aggravating activities and pressure
over the nerves is important. The majority of patients respond to such
measures, but a small proportion require surgery.
Traditional neurosurgical strategies to manage this sometimes difficult
condition have included:
- Sectioning (cutting) or avulsion (removal) of the occipital nerves.
This procedure frequently fails, may cause significant scalp numbness,
and may occasionally lead to a more severe (‘deafferentation’)
pain syndrome. It is therefore usually not recommended as an initial
surgical approach.
- Radiofrequency ablation (controlled heating) of the offending nerve
may yield substantial symptomatic benefit, but the recurrence rate
is high.
- If the C2 nerve root ganglion is thought to be compressed in the
upper spine (between the C1 vertebra arch and C2 vertebra lamina),
surgical decompression may be of benefit.
- Symptomatic atlantoaxial subluxation may warrant a C1-2 fusion.
Peripheral nerve stimulation of occipital nerves has recently emerged
as an effective, well-tolerated, and low-risk technique in patients with
intractable occipital neuralgia. Over 70% of patients appear to benefit
from this new technique.
|